Headline
The latest stories from AHA Today.
The AHA released a new issue of the COVID-19 Snapshot underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.
The hospital workforce shortage crisis demands immediate attention from government and workable solutions, such as lifting the cap on Medicare-funded physician residencies, boosting support for nursing schools and faculty, providing scholarships and loan forgiveness, expediting visas for highly…
Many staffing agencies have been exploiting the severe shortage of health care personnel during the COVID-19 pandemic by charging uniformly high prices in a manner that suggests widespread coordination and abuse of market position, the AHA and American Health Care Association/National Center for…
The AHA, American Medical Association and American Nurses Association released a joint statement urging Americans to donate blood.
The departments of Labor, Health and Human Services, and the Treasury released their latest report to Congress on group health plan compliance with the Mental Health Parity and Addiction Equity Act of 2008, and requirements under the Consolidated Appropriations Act of 2021 for the plans to provide…
In response to an AHA request for clarification, the Centers for Medicare & Medicaid Services released more information to clarify how its recently updated guidance on hospital co-location with other hospitals or health care facilities might apply to critical access hospitals and physician…
Leaders of the Senate Health, Education, Labor, and Pensions Committee released for comment until Feb. 4 a discussion draft of bipartisan legislation to strengthen the nation’s public health and medical preparedness and response systems in the wake of the COVID-19 pandemic.
Amid a resurgent COVID-19 and annual flu season, the AHA has released new resources that hospitals and health systems can use to encourage communities to stay healthy and protect themselves.
Based on recent data on omicron variant susceptibility to monoclonal antibodies, the Food and Drug Administration revised its emergency use authorizations for the combination therapies bamlanivimab and etesevimab and REGEN-COV (casirivimab and imdevimab) to exclude geographic regions where the…
The Health Resources and Services Administration will distribute $2 billion in a second wave of Provider Relief Fund “Phase 4” payments to providers who experienced revenue losses and expenses related to the COVID-19 pandemic based on changes in operating revenues and expenses from July 1, 2020, to…